Dual Attention Graph Convolutional Network Fusing Imaging and Genetic Data for Early Alzheimer's Disease Diagnosis
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a new dual attention graph convolutional network for early Alzheimer's Disease (AD) diagnosis, integrating imaging and genetic data for improved accuracy. The method shows high proficiency in identifying early-stage AD, aiding clinical decisions.
Area Of Science
- Neuroscience
- Medical Imaging
- Genomics
- Artificial Intelligence
Background
- Alzheimer's Disease (AD) is a major neurodegenerative disorder demanding early diagnosis for effective intervention.
- Current diagnostic methods may lack the precision needed for early-stage detection.
- Integrating multi-modal data holds promise for improving diagnostic accuracy.
Purpose Of The Study
- To develop and validate a novel deep learning approach for early Alzheimer's Disease diagnosis.
- To leverage multi-modal data, including imaging and genetic information, for enhanced diagnostic performance.
- To improve the accuracy and efficiency of early AD identification to support clinical decision-making.
Main Methods
- A dual attention graph convolutional network (GCN) was designed to integrate multi-modal data.
- Image and genetic data were used to construct subject-specific graphs.
- GCNs extracted embedded information, with self-attention and cross-attention mechanisms fusing multi-modal states.
- The Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset was used for validation.
Main Results
- The proposed dual attention GCN model demonstrated high proficiency in diagnosing early-stage AD.
- The integration of multi-modal data through attention mechanisms significantly enhanced diagnostic precision.
- Experimental validation on the ADNI dataset confirmed the model's efficacy.
Conclusions
- The novel dual attention graph convolutional network offers a promising tool for early Alzheimer's Disease diagnosis.
- The method effectively fuses multi-modal imaging and genetic data for improved diagnostic accuracy.
- This approach can assist clinicians in making timely and accurate AD diagnoses.

